New funding of €29 million will be made available by the European Commission:

– €17 for transporting vital aid supplies and equipment to the affected countries, evacuation of infected international aid workers to hospitals in Europe and training and deploying health workers to the ground. Money will also reinforce local health facilities.
– €12 million in assistance to the neighbours of the affected countries, to help them prepare for the risk of an Ebola outbreak through early detection and public awareness measures.

The new aid was announced by Christos Stylianides, EU Ebola Coordinator and Commissioner for Humanitarian Aid and Crisis Response upon his return from Sierra Leone, Liberia and Guinea where he gathered first-hand knowledge of the challenges and considered the next steps in the EU response.

Sweden has announced that it will deploy, via the EU Civil Protection Mechanism, 42 doctors, nurses and other health personnel who will run a treatment centre on the ground. Following his call for more medical workers where they are needed the most, Commissioner Stylianides welcomed this announcement and commended Sweden on acting decisively and making good use of the EU’s coordination assets.

The new funding brings the European Commission’s assistance for this emergency to €373 million. The European Union’s total contribution is close to €1.1 billion. This financial aid is in addition to essential equipment, medical personnel from Member States and coordinated delivery of support.

Background

Commissioner Stylianides and Commissioner Andriukaitis visited Guinea, Sierra Leone and Liberia. During their mission, they discussed the challenges with the national authorities, representatives of EU Member States and humanitarian organisations. They met with Ebola survivors and European aid workers.

They also discussed procedures for exit screening of travellers flying to Belgium, France and other countries and the progress on the development of vaccines and treatment for Ebola. The EU is providing support for the testing of one candidate vaccine. First results are expected in December and if successful, more extensive “Phase 2” studies will begin early in 2015.

The European Union has been active in the response to the Ebola emergency from the start. In addition to funding, the EU has deployed mobile laboratories, humanitarian experts and specialists in infectious diseases to the region. Coordinated by the European Commission, the Member States are providing aid supplies, medical equipment, ambulances and field hospitals. The Commission is also supporting the building and recovery of the health services of the affected countries. Moreover, together with the European pharmaceutical industry, the Commission has made available €280 million for research in vaccines and medication.